Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 478017, 6 pages
http://dx.doi.org/10.1155/2015/478017
Research Article

Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms

1Yorkshire Regional Genetics Service, St. James’s University Hospital, Leeds LS9 7TF, UK
2Leeds Institute of Cancer & Pathology, University of Leeds, St. James’s University Hospital, Leeds LS9 7TF, UK
3Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, St. James’s University Hospital, Leeds LS9 7TF, UK

Received 8 June 2015; Accepted 10 August 2015

Academic Editor: Pankaj Kumar

Copyright © 2015 George J. Burghel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. De La Chapelle, “Genetic predisposition to colorectal cancer,” Nature Reviews Cancer, vol. 4, no. 10, pp. 769–780, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Stratton, P. J. Campbell, and P. A. Futreal, “The cancer genome,” Nature, vol. 458, no. 7239, pp. 719–724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Vogelstein and K. W. Kinzler, “Cancer genes and the pathways they control,” Nature Medicine, vol. 10, no. 8, pp. 789–799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Balmain, J. Gray, and B. Ponder, “The genetics and genomics of cancer,” Nature Genetics, vol. 33, supplement, pp. 238–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. L. D. Wood, D. W. Parsons, S. Jones et al., “The genomic landscapes of human breast and colorectal cancers,” Science, vol. 318, no. 5853, pp. 1108–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Greenman, P. Stephens, R. Smith et al., “Patterns of somatic mutation in human cancer genomes,” Nature, vol. 446, pp. 153–158, 2007. View at Google Scholar
  7. J. E. Dancey, P. L. Bedard, N. Onetto, and T. J. Hudson, “The genetic basis for cancer treatment decisions,” Cell, vol. 148, no. 3, pp. 409–420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Tran, A. M. K. Brown, P. L. Bedard et al., “Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial,” International Journal of Cancer, vol. 132, no. 7, pp. 1547–1555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Allegra, J. M. Jessup, M. R. Somerfield et al., “American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy,” Journal of Clinical Oncology, vol. 27, no. 12, pp. 2091–2096, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. S. Karapetis, S. Khambata-Ford, D. J. Jonker et al., “K-ras mutations and benefit from cetuximab in advanced colorectal cancer,” The New England Journal of Medicine, vol. 359, no. 17, pp. 1757–1765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. M. Frampton, A. Fichtenholtz, G. A. Otto et al., “Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing,” Nature Biotechnology, vol. 31, no. 11, pp. 1023–1031, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Meldrum, M. A. Doyle, and R. W. Tothill, “Next-generation sequencing for cancer diagnostics: a practical perspective,” Clinical Biochemist Reviews, vol. 32, no. 4, pp. 177–195, 2011. View at Google Scholar · View at Scopus
  13. P. A. Chambers, L. F. Stead, J. E. Morgan et al., “Mutation detection by clonal sequencing of pcr amplicons and grouped read typing is applicable to clinical diagnostics,” Human Mutation, vol. 34, no. 1, pp. 248–254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Mamanova, A. J. Coffey, C. E. Scott et al., “Target-enrichment strategies for next-generation sequencing,” Nature Methods, vol. 7, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Pritchard, S. J. Salipante, K. Koehler et al., “Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens,” Journal of Molecular Diagnostics, vol. 16, no. 1, pp. 56–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Kanagal-Shamanna, B. P. Portier, R. R. Singh et al., “Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics,” Modern Pathology, vol. 27, no. 2, pp. 314–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Morgan, I. M. Carr, E. Sheridan et al., “Genetic diagnosis of familial breast cancer using clonal sequencing,” Human Mutation, vol. 31, no. 4, pp. 484–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Watson, L. A. Crinnion, J. E. Morgan et al., “Robust diagnostic genetic testing using solution capture enrichment and a novel variant-filtering interface,” Human Mutation, vol. 35, no. 4, pp. 434–441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. F. Taylor, F. M. Platt, C. D. Hurst, H. H. Thygesen, and M. A. Knowles, “Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes,” Human Molecular Genetics, vol. 23, no. 8, pp. 1964–1974, 2014. View at Publisher · View at Google Scholar · View at Scopus